CANNABIS HIGH EXPERIENCE - AN OVERVIEW

Recurrent use of cannabis is connected to a higher hazard of acquiring schizophrenia or other psychoses in people who are predisposed to these conditions.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis to be a Program III drug. This rescheduling will acknowledge that cannabis has reputable clinic